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PCardiac Imaging
Prognostic Value of Multidetector
Coronary Computed Tomographic
Angiography for Prediction of All-Cause Mortality
James K. Min, MD,*† Leslee J. Shaw, PHD,‡ Richard B. Devereux, MD,* Peter M. Okin, MD,*
Jonathan W. Weinsaft, MD,* Donald J. Russo, MD,† Nicholas J. Lippolis, MD,†
Daniel S. Berman, MD,‡ Tracy Q. Callister, MD†
New York, New York; Hendersonville, Tennessee; and Los Angeles, California
Objectives The purpose of this study was to examine the association of all-cause death with the coronary computed tomo-
graphic angiography (CCTA)-defined extent and severity of coronary artery disease (CAD).
Background The prognostic value of identifying CAD by CCTA remains undefined.
Methods We examined a single-center consecutive cohort of 1,127 patients 45 years old with chest symptoms. Steno-
sis by CCTA was scored as minimal (30%), mild (30% to 49%), moderate (50% to 69%), or severe (70%) for
each coronary artery. Plaque was assessed in 3 ways: 1) moderate or obstructive plaque; 2) CCTA score modi-
fied from Duke coronary artery score; and 3) simple clinical scores grading plaque extent and distribution. A
15.3  3.9-month follow-up of all-cause death was assessed using Cox proportional hazards models adjusted for
pretest CAD likelihood and risk factors. Deaths were verified by the Social Security Death Index.
Results The CCTA predictors of death included proximal left anterior descending artery stenosis and number of vessels
with 50% and 70% stenosis (all p  0.0001). A modified Duke CAD index, an angiographic score integrating
proximal CAD, plaque extent, and left main (LM) disease, improved risk stratification (p  0.0001). Patients with
50% stenosis had the highest survival at 99.7%. Survival worsened with higher-risk Duke scores, ranging from
96% survival for 1 stenosis 70% or 2 stenoses 50% (p  0.013) to 85% survival for 50% LM artery steno-
sis (p  0.0001). Clinical scores measuring plaque burden and distribution predicted 5% to 6% higher absolute
death rate (6.6% vs. 1.6% and 8.4% vs. 2.5%; p  0.05 for both).
Conclusions In patients with chest pain, CCTA identifies increased risk for all-cause death. Importantly, a negative CCTA portends
an extremely low risk for death. (J Am Coll Cardiol 2007;50:1161–70) © 2007 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.067i
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yardiovascular disease remains the leading cause of mor-
idity and mortality in the world. Because efficacious ther-
pies exist to reduce cardiovascular events, it is vital to
dentify individuals at high risk for adverse outcomes.
See page 1171
Noninvasive evaluation of symptomatic patients to fur-
her stratify risk beyond traditional cardiac risk factor
coring has primarily relied on stress nuclear myocardial
erfusion imaging and echocardiography (1). The recent
rom the *Greenberg Division of Cardiology, Weill Medical College of Cornell
niversity, New York Presbyterian Hospital, New York, New York; †Tennessee
eart and Vascular Institute, Hendersonville, Tennessee; and the ‡Cedars-Sinai
edical Center, Los Angeles, California. The first two authors contributed equally to
his work.p
Manuscript received November 7, 2006; revised manuscript received March 5,
007, accepted March 20, 2007.ntroduction of multidetector coronary computed tomo-
raphic angiography (CCTA) offers a novel noninvasive
pproach for evaluation of coronary and cardiac structure
nd function (2,3). Current-generation CT scanners permit
igh diagnostic accuracy for detection of and high negative
redictive value to exclude obstructive coronary lesions (4).
To date, the prognostic value of CCTA in patients
resenting with chest symptoms is only beginning to be
xamined (5,6). Therefore, the goal of the present study was
o determine whether use of CCTA as the primary nonin-
asive imaging modality in the evaluation of patients pre-
enting with chest symptoms would offer incremental prog-
ostic value for prediction of all-cause mortality.
ethods
atients. We evaluated 1,127 consecutive patients 45
ears of age from January 2004 to February 2005 who
resented with chest symptoms (pain, tightness, palpita-
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Prognostic Value of CCTA September 18, 2007:1161–70tions, and dyspnea), thought
not to represent acute coronary
syndromes, for which CCTA
coronary angiography was the
primary diagnostic imaging mo-
dality. Patients were referred for
evaluation by CCTA for a variety
of indications, including evalua-
tion of symptoms, signs of car-
iac disease (abnormal rest or stress test), or asymptomatic
atients with peripheral arterial disease, cerebrovascular
isease, or multiple coronary artery disease (CAD) risk
actors. Symptoms included typical angina, atypical angina,
yspnea, or excessive fatigue. Patients classified by Diamond
t al. as nonanginal chest pain were placed into the atypical
ngina group (7). Pretest likelihood of CAD was deter-
ined based on criteria from the American College of
ardiology/American Heart Association guidelines on sta-
le chest pain, with patients grouped as having a low
ikelihood (30%), intermediate likelihood (30% to 69%),
r high likelihood (70%). Of the 1,127, 30% were
lassified with low, 50% with intermediate, and 20% with
igh CAD likelihood. Patients were referred from outpa-
ient clinics (66%), inpatient wards (20%), and the emer-
ency department (14%). All patients were in normal sinus
hythm and were capable of the breath hold needed for
CTA.
Patients with heart rates70 beats/min were given 5-mg
ntravenous metoprolol at 5-min intervals to a total dose of
5 mg. If the patient’s heart rate did not drop below 70
eats/min, CCTA was performed at the lowest heart rate.
Before the initiation of the scan, we prospectively col-
ected information on the presence of categoric cardiac risk
actors in each individual. Systemic arterial hypertension
as defined as a documented history of high blood pressure
r treatment with antihypertensive medications. Diabetes
ellitus was defined by diagnosis of diabetes made previ-
usly by a physician and/or use of insulin or oral hypogly-
emic agents. Dyslipidemia was defined as known but
ntreated dyslipidemia or current treatment with lipid-
owering medications. A positive smoking history was
efined as current smoking or cessation of smoking within
months of testing. Family history of coronary heart disease
as determined by patient query.
can protocol and image reconstruction. All scans were
erformed with a 16-slice multidetector CT scanner (Light-
peed Pro 16, GE Healthcare, Milwaukee, Wisconsin).
maging of a test bolus of contrast was performed at 2 mm
uperior to the take-off of the left main coronary artery for
recise timing of contrast injection. During the CCTA
ngiography acquisition, 100-ml iodinated contrast (Isovue
70, Bracco Diagnostics, Princeton, New Jersey) was in-
ected followed by a 50-ml saline flush. Monophasic
ontrast-enhanced CCTA of the chest was performed, with
nitiation of the scan at the apices of the lung and termi-
Abbreviations
and Acronyms
CAD  coronary artery
disease
CCTA  coronary
computed tomographic
angiographyation of the scan at the level of the diaphragm. Contrast timing was performed to optimize uniform contrast en-
ancement of the coronary arteries. The scan parameters
ere: 16  0.625 mm collimation, tube voltage 120 mV,
ffective 400 to 650 mA. Estimated radiation doses ranged
rom 10 to 25 mSv.
Helical scan data were obtained with retrospective elec-
rocardiographic gating. Images were reconstructed imme-
iately after completion of the scan in a consistent manner
o identify motion-free coronary artery images. Electrocar-
iographically gated datasets were reconstructed at 70%,
5%, and 80% of the cardiac cycle after the QRS complex to
dentify central diastole, with additional datasets recon-
tructed at 40%, 45%, and 50% of the cardiac cycle to
dentify central early diastole. Optimal phase reconstruction
as assessed by comparison of different phases, and the
hase with the least amount of coronary artery motion was
hosen for analysis. Multiple phases were used for image
nterpretation if minimal coronary artery motion was dif-
erent for different arteries. The CCTAs were evaluated on
-dimensional maximum intensity projections in oblique
ardiocentric views that focused on coronary arterial seg-
ents for optimal viewing. Two orthogonal thin maximal
ntensity projection cardiocentric views approximating tra-
itional coronary angiography angles were used for the left
nterior descending, left circumflex, and right coronary
rtery circulations. Three-dimensional rotation was per-
ormed, when necessary, to focus on diagonal and marginal
ranch vessels.
For CCTAs with suboptimal image quality, multiphase
econstruction was employed for additional points within
he cardiac cycle for identification of phases with the least
mount of cardiac motion artifact. In other cases, multisec-
or reconstruction algorithms were employed to optimize
mage quality. Three-dimensional views using curved mul-
iplanar reformation and short-axis cross-sectional viewing
echniques were additionally used to enhance detection of
bstructive coronary plaque, if necessary. In all individuals,
rrespective of image quality, every arterial segment was
cored. If a coronary artery segment was uninterpretable
ven despite these multiple techniques, the unevaluable
egment was scored similarly to the most proximal segment
hich was evaluable.
oninvasive CCTA analyses. All scans were analyzed by
cardiologist with experience interpreting several thousand
CTA scans. Coronary segments were visually scored for
he presence of coronary plaque. The coronary artery tree
as divided into 16 separate segments based on a
odified AHA classification (left main artery; proximal, mid,
nd distal left anterior descending artery; proximal, mid, and
istal diagonal/intermediate branch; proximal, mid and distal
eft circumflex artery; proximal, mid, and distal obtuse
arginal branch; and proximal, mid, and distal right coro-
ary artery) (8). In cases where multiple diagonal or obtuse
arginal branches were present, plaque was graded based on
he branch with the largest luminal diameter and/or serving
he largest area of myocardium.
w
w
a
p
C
s
m
d
c
m
(
t
b
s
t
p
c
w
v
f
o
b
t
1
v
C
c
i
p
d
t
a
r
s
o
v
d
s
l
t
b
d
n
s
t
s
F
t
w
C

i
3
2
t
s
p
5
p
s
h
p
1
a
s
e
1163JACC Vol. 50, No. 12, 2007 Min et al.
September 18, 2007:1161–70 Prognostic Value of CCTAIn each coronary artery segment, coronary atherosclerosis
as defined as tissue structures 1 mm2 that existed either
ithin the coronary artery lumen or adjacent to the coronary
rtery lumen that could be discriminated from surrounding
ericardial tissue, epicardial fat, or the vessel lumen itself.
oronary artherosclerotic lesions were quantified for steno-
is by visual estimation. Stenosis was graded as none or very
ild (30% estimated obstruction of coronary luminal
iameter), mild (30% to 49% estimated obstruction of
oronary luminal diameter), moderate (50% to 69% esti-
ated obstruction of coronary luminal diameter), or severe
70% estimated obstruction of coronary luminal diame-
er). Percentage obstruction of coronary artery lumen was
ased on a comparison of the luminal diameter of the
egment exhibiting obstruction to the luminal diameter of
he most normal-appearing site immediately proximal to the
laque (Fig. 1). In instances in which plaque was highly
alcified, 2-dimensional oblique images were also viewed
ithout maximal intensity projection at 0.625-mm isotropic
oxel resolution to minimize partial volume averaging arti-
act of calcium.
Currently, no standardized protocol exists for the grading
f coronary plaque by CCTA. Therefore, coronary arteries
y CCTA were assessed by 3 distinct methods. Two
raditional angiographic predictors of mortality were used:
) the presence of obstructive lesions in major epicardial
essel distributions; and 2) a modified Duke prognostic
AD index. Additionally, simple and intuitive clinical
oronary plaque scores were created which can be easily used
nto daily practice.
First, CCTA scans were assessed to detect obstructive
laque reducing coronary luminal diameter in major epicar-
ial vessels. The CCTA scans were analyzed by identifica-
ion of the number of the 3 major epicardial vessels (left
nterior descending artery, left circumflex artery, and
ight coronary artery) exhibiting moderate (50% ob-
truction of coronary luminal diameter) or severe (70%
bstruction of coronary luminal diameter) plaque. Indi-
iduals exhibiting moderate or severe coronary plaque in
iagonal branches or obtuse marginal branches were con-
idered to possess moderate or severe coronary plaque in the
eft anterior descending artery and left circumflex artery
erritory, respectively. Individuals were also categorized
ased on moderate or severe obstruction of coronary luminal
iameter of the left main artery.
Second, we applied the previously reported Duke prog-
ostic CAD index (9,10), which details the expected 5-year
urvival by the extent and severity of angiographic CAD, to
he CCTA scans. The score comprises 16 angiographic
ubsets that are assigned prognostic weights from 0 to 100.
ive-year cardiovascular survival is inversely proportional to
he prognostic weight; that is, higher scores are associated
ith lower survival. We used a modified Duke prognostic
AD index to further assess prognosis in patients with
50% stenosis. From our cohort, we identified the follow-ng subsets: 1) 50% stenosis (n  430); 2) 2 stenoses h0% to 49% (including 1 artery with proximal disease (n 
70) or 1 vessel with 50% to 69% stenosis; 3) 2 stenoses 50%
o 69% or 1 vessel with 70% stenosis (n  101); 4) 3
tenoses 50% to 69% or 2 vessels with 70% stenosis or
roximal left anterior descending stenosis 70% (n  145);
) 3 vessels 70% stenoses or 2 vessels 70% stenosis with
roximal left anterior descending (n  86); and 6) left main
tenosis 50% (n  106). Patients were assigned to the
ighest disease category.
Third, we constructed three clinical coronary artery
laque scores which are simple and easy to apply:
) segment-stenosis score; 2) segment-involvement score;
nd 3) 3-vessel plaque score (Fig. 2). The segment stenosis
core was used as a measure of overall coronary artery plaque
xtent. Each individual coronary segment was graded as
Figure 1 Grading of Plaque Severity
(A) Examples of moderate and severe extent of noncalcified plaque of the left
anterior descending artery. (B) Examples of mild, moderate, and severe extent
of mixed plaque of the left anterior descending artery. (C) Examples of mild,
moderate, and severe extent of calcified plaque of the left anterior descending
artery. Arrows indicate coronary artery plaque.aving no to severe plaque (i.e., scores from 0 to 3) based on
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Prognostic Value of CCTA September 18, 2007:1161–70xtent of obstruction of coronary luminal diameter. Then
he extent scores of all 16 individual segments were summed
o yield a total score ranging from 0 to 48. As a measure of
verall coronary artery plaque distribution, a segment in-
olvement score was calculated. The segment involvement
core was calculated as the total number of coronary artery
egments exhibiting plaque, irrespective of the degree of
uminal stenosis within each segment (minimum  0;
aximum  16). Finally, a 3-vessel plaque score was
alculated as 0 or 1 based on the coexisting presence of any
laque in the left anterior descending, left circumflex, and
ight coronary arteries, irrespective of severity.
ollow-up. The primary end point was time to death from
ll causes. All patients provided informed consent for
ollow-up. Follow-up procedures were approved by our
enter’s institutional review board. Death status was ascer-
ained by querying the Social Security Death Index. Death
tatus was ascertained in all patients (i.e., 100% follow-up).
tatistical analysis. We used SPSS version 12.0 (SPSS
Figure 2 Coronary Artery Tree Model
Depicting Coronary Artery Plaque Scores
Segment stenosis score was calculated by summation of moderate plaque in
the proximal right coronary artery (2)  mild plaque in the proximal left anterior
descending artery (1)  moderate plaque in the mid left anterior descending
artery (2)  severe plaque in the proximal right coronary artery (3). In this
example, the segment stenosis score is 8 out of a possible 48. Segment
involvement score was calculated by summation of the absolute number of cor-
onary segments exhibiting plaque, i.e., the proximal right coronary artery (1) 
proximal left anterior descending artery (1)  mid left anterior descending
artery (1)  proximal right coronary artery (1). In this example, the segment
involvement score is 4 out of a possible 16. Three-vessel plaque score was
calculated as a binary variable to indicate the presence or absence of 3-vessel
coronary artery plaque. Three-vessel plaque score was considered positive if
there was concurrent presence of plaque in the left anterior descending
artery, left circumflex artery, and right coronary artery. In this example, the
3-vessel plaque score is 1 out of a possible 1. Severe proximal plaque
score was measured by presence of severe plaque in the proximal portion of
the left anterior descending artery, left circumflex artery, or right coronary
artery. In this example, the severe proximal plaque score is 1 out of a possible
3. Left main plaque is measured by any plaque within the left main artery. In
this example, the left main plaque score is 0 out of a possible 1.nc., Chicago, Illinois) for all statistical analyses. Categoric aariables are presented as frequencies and continuous vari-
bles as mean  1 SD. Variables were compared with
hi-square statistic for categoric variables and by Student
npaired t test for continuous variables. Time to death from
ll causes (n  39) was calculated using univariable Cox
roportional hazards models. Risk-adjusted models were
lso devised including multivariable stepwise models adjust-
ng for baseline cardiac risk factors. Multivariable models
ere limited to no more than 4 variables to avoid model
verfitting. Relative risk ratios were calculated with 95%
onfidence intervals (CIs) based on binomial distributions.
2-tailed p value of0.05 was considered to be statistically
ignificant. In each case, the proportional hazards assump-
ion was met. Finally, we also evaluated effect modification
sing interaction terms in our Cox models. In particular, we
xamined the predictive value of CCTA measures by age.
We performed a post hoc power calculation to compare
urvival in patients with no to mild plaque versus those with
-vessel or left main disease (  0.80;   0.05), with our
urrent sample yielding sufficient statistical power to detect
ifferences in mortality between these groups or any 2
roups with change in survival rates of 5% or greater.
esults
linical characteristics of the CCTA cohort. Of the 1,127
atients, 57% were women with an average age of 61.7 10
ears (range 45 to 89 years) (Table 1). Patient characteristics
re categorized according to coronary artery plaque score by
he Duke prognostic CAD index. Based upon gradations of
AD as defined by the Duke prognostic CAD index,
atients exhibiting increasing levels of coronary artery
laque tended to be older (p  0.0001), male (p  0.0001),
iabetic (p  0.0001), hyperlipidemic (p  0.0001), and
ypertensive (p  0.0001) and had a higher prevalence of
nown coronary artery disease (p  0.0001). Patients with
igher levels of coronary plaque exhibited higher rates of
ypical angina but lower rates of dyspnea/fatigue (p 
.0001). Individuals exhibiting more coronary plaque had
igher pretest likelihood of significant coronary artery dis-
ase (p  0.0001).
linical characteristics predicting near-term mortality.
urvival was evaluated after a mean follow-up period of 15.3
3.9 months (Table 2). At the completion of follow-up, a
otal of 39 (3.5%) deaths were reported. In univariable Cox
odels, older age, lack of treatment for dyslipidemia, and
o family history of coronary heart disease were associated
ith mortality. Cumulative survival by pretest likelihood of
AD was 99.2% for low, 96.7% for intermediate (relative
isk 3.78 [95% CI 1.1 to 12.8]; p  0.033), and 91.5% for
igh likelihood patients (relative risk 8.0 [95% CI 2.4 to
7.2]; p  0.001).
nivariable CCTA models estimating death from all
auses. Patients who died had significantly higher visual
stimates of coronary stenosis in the left main coronary
rtery and the proximal portions of the left anterior de-
s
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September 18, 2007:1161–70 Prognostic Value of CCTAcending, diagonal, circumflex, first marginal, and right
oronary arteries (all p  0.001) (Tables 3 and 4). All-cause
eath was predicted by moderate (Fig. 3) or severe (Fig. 4)
oronary obstruction of luminal diameter in any coronary
rtery (p  0.007 and p  0.001, respectively), any severe
roximal stenosis (p  0.001), and any left main or left
nterior descending artery stenosis (p  0.001) (Fig. 5).
linical Characteristics of the 1,127 Patients in the Study Registryndex for No to Minimal (<30%) Mild (30% to 49%), Moderate (50
Table 1 Clinical Characteristics of the 1,127 Patients in the SIndex for No to Minimal (<30%), Mild (30% to 49%), M
<50%
Stenosis
>2 Mild Stenoses
With Proximal
CAD in 1 Artery or
1 Moderate
Stenosis
2 Mod
Stenos
1 Se
Sten
n 430 270 10
Age (yrs) 56  8 57  9 59 
Female gender 73% 69% 54
Diabetes 10% 17% 18
Family history of CAD 65% 60% 68
Hyperlipidemia 44% 52% 53
Hypertension 49% 64% 68
Current smoker 24% 36% 30
History of PAD/CVD 2% 2% 2
Known CAD 4% 16% 18
Cardiac arrhythmia 4% 7% 7
Positive stress test 2% 9% 5
Chest pain
Typical angina 2% 4% 5
Atypical angina 66% 51% 52
Asymptomatic 28% 40% 39
Dyspnea/fatigue 5% 5% 5
Pretest likelihood*
Low 40% 38% 31
Intermediate 51% 55% 48
High 9% 5% 22
Pretest likelihood is defined by age, gender, and anginal symptoms based on American Colleg
ategorized as high likelihood.
CAD  coronary artery diesease; CCTA  coronary computed tomography angiography; CVD 
linical Characteristicsf the Study Cohort by Survival Status
Table 2 Clinical Characteristicsof the Study Cohort by Survival Status
Alive
(n  1,088)
Dead
(n  39) p Value
Age (yrs) 59.1  10 71.5  11 0.001
Male gender 42.6% 48.7% 0.45
Diabetes 16.7% 17.9% 0.84
Hypertension 56.6% 53.8% 0.73
Dyslipidemia 52.9% 35.9% 0.04
Smoking history 26.7% 33.3% 0.37
Family history of CAD 66.3% 46.2% 0.01
Pretest likelihood 0.001
Low 30.7% 7.7%
Intermediate 47.6% 46.2%
High 21.7% 46.2%ebbreviations as in Table 1.The Duke prognostic CAD index was a significant
redictor of all-cause mortality (Fig. 6). Also, clinical
oronary artery plaque scores—segment stenosis score
Fig. 7) and segment involvement score (Fig. 8)—were
ignificant predictors of all-cause death (p  0.001 and p 
.001, respectively).
ultivariable CCTA models estimating death from all
auses. First, in multivariable Cox regression analysis, con-
idering age, family history, and dyslipidemia, the presence
f plaque in increasing numbers of coronary arteries, mod-
rate (50% to 69% obstruction of coronary luminal diame-
er) and severe (70% obstruction of coronary luminal
iameter) plaque, and plaque in the left main artery were
ndependent predictors of all-cause mortality (p 0.001 for
oth moderate and severe) (Figs. 3 and 4). Also, in
ultivariable risk-adjusted Cox proportional hazards
odels, subsets of patients with increasing plaque severity in
he proximal left anterior descending artery exhibited higher
ates of all-cause death (p  0.001) (Fig. 5).
Second, in parallel multivariable Cox proportional haz-
rds analysis adjusted for the same covariates, the Duke
rognostic CAD index was a significant predictor of all-
ause mortality (Fig. 6). In particular, subsets of patients
CTA Findings by the Duke Prognostic CAD69%), and Severe (>70%) Coro ary Stenosis
Registry of CCTA Findings by the Duke Prognostic CAD
ate (50% to 69%), and Severe (>70%) Coronary Stenosis
3 Moderate
Stenoses,
2 Severe
Stenoses, or
Severe
Stenosis in
Proximal
LAD
3 Severe
Stenoses or
2 Severe
Stenoses in
Proximal
LAD
>50% Left
Main
Stenosis p Value
145 86 106
60  10 64  10 67  10 0.0001
39% 30% 47% 0.0001
22% 27% 30% 0.0001
63% 63% 69% 0.82
55% 71% 69% 0.0001
59% 62% 68% 0.0001
32% 27% 26% 0.32
2% 2% 4% 0.41
24% 30% 20% 0.0001
3% 2% 6% 0.54
2% 1% 6% 0.015
0.0001
4% 2% 4%
36% 33% 35%
50% 54% 48%
10% 12% 13%
0.0001
20% 19% 20%
53% 41% 41%
28% 39% 39%
rdiology/American Heart Association Stable Angina Guidelines. Patients with known CAD were
ascular disease; LAD  left anterior descending artery; PAD  peripheral artery disease.of C% to
tudy
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Prognostic Value of CCTA September 18, 2007:1161–70isk) include: 1) individuals with 2 segments exhibiting
oderate plaque or 1 segment exhibiting severe plaque (p
.013); 2) individuals with 3 segments exhibiting moderate
laque, 2 segments exhibiting severe plaque, or severe
laque in the proximal left anterior descending artery (p 
.002); 3) individuals with 3 segments exhibiting severe
laque or 2 segments exhibiting severe plaque that includes
he proximal left anterior descending artery (p  0.001);
nd 4) moderate or severe plaque of the left main artery
p  0.0001) (Fig. 6).
Finally, in multivariable Cox regression analyses, adjust-
ng for age, family history, and dyslipidemia, clinical coro-
ary artery plaque scores were independent predictors of
ll-cause death: segment stenosis score (p  0.01), segment
nvolvement score (p  0.01), and triple-vessel plaque score
resence and Severity of Plaque by CCTA in Different Coronary Art
Table 3 Presence and Severity of Plaque by CCTA in Different
Alive
(n  1,088)
n % Stenos
Left main artery 158 14.5% 0.26
Left anterior descending artery
Proximal 546 50.2% 1.15
Mid 359 33.0% 0.70
Distal 55 5.1 0.10
Diagonal artery
Proximal 218 20.0% 0.44
Mid 57 5.2% 0.09
Distal 18 1.7% 0.03
Left circumflex artery
Proximal 368 33.8% 0.72
Mid 154 14.2% 0.26
Distal 23 2.1% 0.04
Obtuse marginal artery
Proximal 176 16.2% 0.34
Mid 50 4.6% 0.07
Distal 16 1.5% 0.02
Right coronary artery
Proximal 380 34.9% 0.74
Mid 229 21.0% 0.40
Distal 75 6.9% 0.14
Total 5
bbreviations as in Table 1.
nivariable and Multivariable Cox Models of CCTA Results for All-C
Table 4 Univariable and Multivariable Cox Models of CCTA Res
CCTA Result
Univariable Hazard
(95% CI)
Any moderate stenosis 2.89 (1.32–6.2
Any severe stenosis 4.31 (1.98–9.3
Moderate or severe coronary stenosis (per segment) 1.07 (1.04–1.1
Any severe proximal stenosis 3.04 (1.62–5.7
Any left main stenosis 5.03 (2.68–9.4
Segment stenosis score (per segment severity) 1.99 (1.48–2.6
Segment involvement score (per segments involved) 1.23 (1.13–1.3
Three-vessel coronary plaque, any severity 4.15 (2.10–8.2Multivariable model adjusted for age, dyslipidemia, and family history.
CI  confidence interval; other abbreviations as in Table 1.p  0.05). When individuals were partitioned into groups
ith a segment stenosis score or segment involvement score
f 5 versus 5, those with higher scores had greater
ll-cause mortality (Figs. 7 and 8). At the mean follow-up
nterval of 15 months for this study population, the absolute
ifference in mortality rate for individuals with scores of 5
ersus 5 was 6.6% versus 1.6%, respectively, for the
egment severity score (absolute difference 5.0%; p  0.05)
nd 8.4% versus 2.5%, respectively, for the segment involve-
ent score (absolute difference 5.9%; p  0.05).
To examine effect modification, interaction terms were
sed for variables that showed significant main effects.
lthough most CCTA variables demonstrated the same
attern of relationship in all age groups, there was signifi-
ant positive interaction with increasing age and the seg-
Segments
ary Arterial Segments
Dead
(n  39)
p Valuere n % Stenosis Score
18 46.2% 0.92 1.13 0.001
30 76.9% 1.97 1.3 0.001
17 43.6% 0.97 1.3 0.12
4 10.3% 0.21 0.7 0.20
19 48.7% 1.18 1.4 0.001
5 12.8% 0.26 0.75 0.03
2 5.1% 0.10 0.5 0.08
24 61.5% 1.51 1.4 0.001
8 20.5% 0.49 1.0 0.04
3 7.7% 0.18 0.6 0.008
19 48.7% 1.18 1.4 0.001
5 12.8% 0.36 1.0 0.001
2 5.1% 0.10 0.5 0.02
25 64.1% 1.59 1.4 0.001
11 28.2% 0.49 0.9 0.50
4 10.3% 0.21 0.7 0.50
11.7
Mortality*
for All-Cause Mortality*
p Value
Risk-Adjusted Hazard Ratio
(95% CI) p Value
0.007 1.37 (0.60–3.11) NS
0.001 2.14 (0.95–4.81) 0.07
0.001 1.05 (1.02–1.09) 0.01
0.001 1.44 (0.74–2.81) NS
0.001 2.65 (1.37–5.12) 0.01
0.0001 1.52 (1.09–2.14) 0.01
0.0001 1.16 (1.05–1.28) 0.004
0.001 2.04 (0.99–4.20) 0.05erial
Coron
is Sco
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September 18, 2007:1161–70 Prognostic Value of CCTAent stenosis score (p 0.01) and the segment involvement
core (p  0.01). Accounting for the significant interaction
ith increasing age rendered the triple-vessel plaque score
onsignificant as a predictor of death (p  0.07). In
ultivariable analysis, when a partition cutoff age of 61
ears was used, segment stenosis score and segment involve-
ent score remained independent predictors of all-cause
ortality and no longer significantly interacted with age.
atient subset analyses. We examined the predictive value
f CCTA findings in several other patient subgroups. These
ncluded patients without any coronary artery plaque, pa-
ients without left main plaque, and patients without prox-
mal left anterior descending artery plaque (Table 5). Indi-
iduals without evident left main plaque, and individuals
ho exhibited no coronary plaque in the proximal left
nterior descending artery exhibited minimally lower rates
Figure 3 Cumulative Survival in Patients
With Moderate (>50%) Plaque by CCTA
Risk-adjusted p  0.001 (controlling for age, family history,
and dyslipidemia). CCTA  coronary computed tomographic angiography
Figure 4 Cumulative Survival in Patients With Severe Plaque
or Moderate/Severe Left Main Plaque by CCTA
Risk-adjusted p  0.001 (controlling for age, family history,
and dyslipidemia). CCTA  coronary computed tomographic angiography.df all-cause mortality (1.6% to 2.2%) than the entire
opulation (3.5%). Of note, the 333 patients with no
etectable coronary plaque by CCTA had a much lower rate
f death than the remainder of the population: 0.3% versus
.8%, respectively (hazard ratio 0.12, 95% CI 0.02 to 0.89;
 0.04) (Table 5). Patients without any left main coronary
rtery plaque exhibited much lower rates of mortality than
hose with left main coronary plaque (p  0.001). The
egative predictive values for all-cause mortality of the
bsence of any plaque, absence of left main plaque, or
bsence of plaque in the proximal left anterior descending
rtery were 99.7%, 97.8%, 98.4%, respectively.
In the present study, follow-up was available in 10 of 39
ndividuals who died. Invasive coronary angiography was
erformed in 2 of these 10 individuals, with 1 undergoing
ercutaneous intervention and the other undergoing coro-
ary artery bypass surgery. The deaths of these individuals
ccurred 93 days and 269 days, respectively, after their
rocedures. In the remaining 8 individuals, no coronary
ngiography or coronary artery bypass surgery was per-
ormed in the follow-up period.
iscussion
he primary results from our registry reveal that measures of
ngiographic disease extent, location, and distribution de-
ected by 3 distinct CCTA grading systems significantly
redicted the risk of all-cause death in individuals present-
ng with chest symptoms. Numerous prognostically valuable
CTA indices were identified. These results extend previ-
us results reported with invasive X-ray angiography.
First, visual estimates of moderate to severe coronary
tenosis by CCTA were associated with a higher mortality
isk compared with less extensive lesions, and the risk of
Figure 5 Cumulative Survival in Patients With Proximal
Left Anterior Descending Artery Plaque by CCTA
Risk-adjusted p  0.001 (controlling for age, family history,
and dyslipidemia). CCTA  coronary computed tomographic angiography.eath increased proportionally with increasing number of
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Prognostic Value of CCTA September 18, 2007:1161–70ajor epicardial vessels involved. Higher risk was also
ssociated with proximal disease, especially when identified
n the left anterior descending coronary artery. Patients with
visual estimate of 50% stenosis had the worst survival
85%) at 1.5 years, compared with a mortality rate of 0.3%
or patients with 50% stenosis.
Second, using a modified Duke prognostic coronary
rtery score, incrementally higher overall risk of death was
dentified in individuals with 2 moderate or 1 severe
tenosis, 3 moderate or 2 severe stenoses, or 3 severe or 2
evere stenoses with proximal left anterior descending artery
nvolvement. Patients exhibiting moderate or severe left
ain coronary plaque by CCTA fared the worst.
Finally, clinical coronary artery plaque scores—namely, seg-
ent stenosis score, segment involvement score, and 3-vessel
laque score assessing overall coronary artery plaque extent,
Figure 6 Cumulative Survival in Patients Exhibiting Plaque by t
Risk-adjusted p  0.001 (controlling for age, family history, and dyslipidemia). LAD
Figure 7 Cumulative Survival in
Patients With or Without SSS of >5
Risk-adjusted p  0.001 (controlling for age, family
history, and dyslipidemia). SSS  segment stenosis score.istribution, and number of coronary vessels involved—were
ll predictive of greater rates of all-cause death.
Each of these high-risk markers significantly predicted
verall mortality independently of other traditional clinical
ardiovascular risk factors, underscoring the incremental
alue of CCTA examination of coronary artery anatomy to
ssess future risk of symptomatic individuals without active
cute coronary syndromes.
Although the identification of a positive CCTA confer-
ing increased risk is of great significance, whether a
egative CCTA coronary angiogram can safely “rule out”
uture risk in symptomatic individuals is of equal, or perhaps
reater, import. In the present study, we found that the
bsence of any coronary artery plaque, of any left main artery
laque, or of any proximal left anterior descending artery
uke Prognostic Coronary Artery Disease Index
ft anterior descending artery.
Figure 8 Cumulative Survival in
Patients With or Without SIS of >5
Risk-adjusted p  0.001 (controlling for age, family
history, and dyslipidemia). SIS  segment involvement score.he D
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September 18, 2007:1161–70 Prognostic Value of CCTAlaque was associated with high negative predictive values
97.8% to 99.7%) for near-term all-cause death.
The prognostic utility of CCTA in evaluation of patients
resenting with chest symptoms documented by the present
tudy should be placed in the context of previously reported
esults from nuclear and echocardiographic stress imaging
11,12). Several indices from these imaging modalities have
een identified as markers of high risk, traditionally defined
s a3% annual mortality rate. These include severe resting
eft ventricular systolic dysfunction (left ventricular ejection
raction 35%), segmental wall motion abnormalities, and
evere perfusion abnormalities. The absolute all-cause mor-
ality rate at the end of 15 months of follow-up was about
% higher with a segment stenosis score5 versus5, with
n even larger 6% absolute difference associated with higher
egment involvement scores (Figs. 7 and 8). These rates
orrespond to 12-month increments of 4.4% and 4.7%,
espectively, indicating that these CCTA indices equal or
xceed the present conventional definitions of “high risk.”
The prognostic value of CCTA should also be placed in the
ontext of earlier investigations examining coronary artery
tenosis and adverse cardiovascular outcomes. Earlier studies
ave demonstrated that myocardial infarctions most often
ccur at lesion sites that have no significant stenosis (i.e.,
uminal stenosis 50%); in contrast, significant stenoses (i.e.,
uminal stenosis 70%) comprise only a minority of myocar-
ial infarctions (13). Indeed, this is likely due to the increased
revalence of nonobstructive coronary artery lesions over ob-
tructive coronary artery lesions. The present investigation
upports these earlier data. In multivariate analysis, the seg-
ent involvement score, a measure of the overall number of
oronary segments exhibiting plaque regardless of stenosis
everity, was significantly predictive of all-cause mortality.
Recent data are emerging that support the notion of the
rognostic value of CCTA. In a study of 100 patients,
undziute et al. (14) examined the prognostic value of
CTA coronary plaque assessment for the combined end
oint of cardiac death, nonfatal myocardial infarction,
nstable angina requiring hospitalization, and revasculariza-
ion. Similar to the results in the present study, obstructive
laque, particularly in the left main or left anterior descend-
ng arteries, conferred the highest risk. Conversely, a normal
CTA was associated with a 0% event rate. These findings
re in keeping with the present data and reinforce the value
f coronary plaque identification by CCTA.
Because the spatial resolution of the CT scanner utilized in
rognostic Value of CCTAesults in Subs ts of Population
Table 5 Prognostic Value of CCTAResults in Subsets of Population
Risk Factor Patients (n) Deaths (n) %
Coronary artery plaque score  0 333 1 0.3%
No left main plaque 951 20 2.1%
No proximal LAD plaque 551 9 1.6%
bbreviations as in Table 1.he current study was limited to 0.625 mm, the ability to vdentify atherosclerotic plaques causing minimal stenosis (e.g.,
5%) was difficult. However, the detection of minimal steno-
is appears to possess limited clinical relevance. When individ-
al coronary artery plaque is considered, increasing luminal
tenosis severity predicts higher event rates. In a 5-year
ollow-up of the CASS (Coronary Artery Surgery Study),
omparison of coronary segments exhibiting minimal (5%
tenosis), mild (5% to 49% stenosis), moderate (50% to 80%)
nd severe plaque (81% to 95% stenosis) revealed 0.7%, 2.3%,
0.1%, and 23.6% of respective segments progressing to total
cclusion (15). These findings confirm the notion that initially
dentified lesion severity is vital for predicting progression of
oronary artery disease. Our clinical outcomes corroborate
hese angiographic findings, because increasing numbers of
egments exhibiting moderate and severe stenosis were more
redictive of death than minimal or mild stenosis.
tudy limitations. The present study is retrospective and
as performed at a single center, which makes it uncertain
hether the results will be equally applicable to other
opulations. The clinical demographic information, cardiac
isk profile, and symptom complex were procured prospec-
ively for each individual, and the end point was all-cause
eath, which disencumbers the current investigation from
nformation bias relating to confounders or ascertainment.
The major outcome of the present analysis was all-cause
ortality, with the etiology of death being of uncertain cause.
xtensive literature is available as to death misclassification
16). However, cardiovascular disease remains the leading
ause of death in this type of patient cohort and, as such, our
esults will have similarities to cardiac-specific models.
hether CCTA is prognostically valuable for the prediction of
ardiac death, ST-segment elevation myocardial infarction, or
ther less stringent end points, such as non–ST-segment
levation myocardial infarction or urgent target vessel revascu-
arization, will require larger multicenter studies.
The prevalence of individuals exhibiting 3-vessel, left main,
nd proximal left anterior descending artery plaque is high in
he current study. Which of these individuals received specific
herapies is not fully known. These data represent actual
linical practice patterns from numerous physicians referring
atients for CCTA at a single center. As such, the reasons a
articular individual may or may not have undergone a specific
reatment, or whether survivors fared better because of more
ptimal treatment and nonsurvivors fared poorly because of
nadequate treatment, are not known.
In the present study, follow-up was available in 10 of 39
ndividuals who died. Invasive coronary angiography was
erformed in 2 of these 10 individuals, with deaths of these
ndividuals occurring 93 and 269 days after their procedures.
n the remaining 8 individuals, no coronary angiography or
oronary artery bypass surgery was performed in the
ollow-up period. These partial results support the notion
hat increased death did not occur as a complication of
ardiac procedures but from other causes.
The present study does not measure overall plaque
olumes. Current-generation CCTA scanners are limited to
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Prognostic Value of CCTA September 18, 2007:1161–700.5- to 0.8-mm isotropic voxel spatial resolution, which
ermits partial volume averaging artifact from calcified
laque. As such, calcified plaque is often overestimated, and
arlier data suggest that noncalcified plaque may be consis-
ently underestimated (17). Recent data indicate that
urrent-generation 64-detector row CT scanners are less
rone to the over- and underestimation of coronary plaque
olumes. Although a few studies to date have attempted to
easure coronary plaque volumes, no accurate software
urrently exists for the automated quantification of noncal-
ified and mixed plaque volumes in large-scale populations.
onclusions and Clinical Implications
ultidetector CCTA performed in a large group of patients
resenting with chest symptoms successfully identified pa-
ients at 5% to 6% higher 15-month absolute risk of
ll-cause death. Our sample is sufficiently powered ( 
.80;   0.05) to detect differences in mortality between
atients with no to mild plaque compared with those with
-vessel or left main disease. The CCTA scores measuring
oronary plaque severity, global coronary artery plaque
xtent, coronary artery plaque distribution, presence of left
ain or left anterior descending artery plaque, and 3-vessel
oronary artery plaque were all predictive of death. Patients
ith normal coronary artery plaque scores, absence of left
ain plaque, or absence of proximal left anterior descending
rtery plaque have a low risk of death during short- to
ntermediate-term follow-up. These results, taken in com-
ination, suggest that CCTA coronary angiography may be
prognostically useful noninvasive imaging modality for the
valuation of patients with chest symptoms. The present
esults reveal the prognostic value of CCTA findings and
rovide the first mortality data which may be used to guide
linical application of this new technology.
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